1
|
Current attitudes and beliefs toward perinatal care orientation before 25 weeks of gestation: The French perspective in 2020. Semin Perinatol 2022; 46:151533. [PMID: 34865886 DOI: 10.1016/j.semperi.2021.151533] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
The survival rate of infants born before 25 weeks of gestational age in France is extremely low compared with that of many other countries: 0%, 1%, and 31% at 22, 23, and 24 weeks' in the last national cohort study. A non-optimal regionalization and variations in practice are prevalent. Some parents in social media and support groups have reported feeling lost and confused with mixed messages leading to lack of trust. These data kindled a major debate in France around perinatal management leading to an investigation exploring neonatologists' perspectives and ways to improve care. The majority (81%) of the responding neonatologists reported more active care and higher survival rates than in 2011, although others continued preferring delivery room comfort care and limited NICU treatment at or before 24 weeks. The desire to improve was an overarching theme in all the respondents' answers to open-ended questions. Barriers to active care included an absence of expertise and of benchmarking to guide optimal care, and limited resources in the NICU and during follow-up - all leading to self-fulfilling prophecies of poor prognosis. Optimization of regionalization, perinatal teamwork and parental involvement, fostering experience by creating specific perinatal centers, stimulating benchmarking, and working with policy makers to allow better long-term outcomes could enable higher survival.
Collapse
|
2
|
Lamau MC, Ruiz E, Merrer J, Sibiude J, Huon C, Lepercq J, Goffinet F, Jarreau PH. A new individualized prognostic approach to the management of women at risk of extreme preterm birth in France: Effect on neonatal outcome. Arch Pediatr 2021; 28:366-373. [PMID: 34059380 DOI: 10.1016/j.arcped.2021.04.005] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/11/2020] [Revised: 03/19/2021] [Accepted: 04/16/2021] [Indexed: 11/17/2022]
Abstract
INTRODUCTION After discussion with the parents, periviable infants can receive either active treatment or palliative care. The rate of active treatment in France is lower than in other developed countries, as is the survival rate of infants in this gestational age range. This study's main objective was to assess the effect of a standardized perinatal management protocol (EXPRIM) on the neonatal outcome of children born before 27 weeks of gestation. METHODS A before-and-after study was conducted in the two level-3 hospitals of the Risks and Pregnancy DHU to compare two 16-month periods. The EXPRIM protocol was based on routine administration of prenatal corticosteroid therapy and a scheduled combined obstetric-pediatric group prenatal prognostic evaluation, not based solely on gestational age. The study included all births between 22 weeks and 26 weeks+6 days of gestation, except in utero deaths diagnosed at admission and medical terminations of pregnancy for fetal malformation, both excluded. The principal endpoint was survival without severe neonatal morbidity. RESULTS The study included 267 women: 116 (128 newborns) in period 1 and 151 (172 newborns) in period 2. The median gestational age at admission to the maternity unit was 2.5 days younger in period 2, and the number of women admitted at 22-23 weeks doubled in period 2 (59 vs 29, respectively). Overall, the rates of live births, NICU transfer, and survival without severe morbidity were similar during the two periods. More infants were liveborn between 22 and 24 weeks in period 2 (66 vs 43). Of all newborns transferred to the NICU, 26 (29%) survived without severe morbidity in period 1 and 46 (39%) in period 2. After multivariate analysis, survival without severe morbidity did not differ significantly. CONCLUSION Implementation of the EXPRIM protocol led to active treatment of more mothers and their children at the border of viability, and increased the number of children who survived without severe morbidity even if, overall, there was no statistically significant difference in percentage.
Collapse
Affiliation(s)
- M C Lamau
- Maternité Port-Royal, AP-HP, APHP, Centre-Université de Paris, FHU PREMA, 123, Bd de Port-Royal, 75014 Paris, France
| | - E Ruiz
- Service de médecine et réanimation néonatales de Port-Royal, AP-HP, APHP, Centre-Université de Paris, FHU PREMA, 123, Bd de Port-Royal, 75014 Paris, France
| | - J Merrer
- Clinical Research Unit of Paris Descartes Necker Cochin, AP-HP, 123, Bd de Port-Royal, 75014 Paris, France; Université de Paris, INSERM U1153, Équipe de recherche en Epidémiologie Obstétricale, Périnatale et Pédiatrique (EPOPé), Centre de Recherche Épidémiologie et Biostatistique Sorbonne Paris Cité (CRESS), 123, Bd de Port-Royal, 75014 Paris, France
| | - J Sibiude
- Service de Gynécologie-Obstétrique, AP-HP, Nord-Université de Paris, Hôpital Louis Mourier, DMU Gynécologie-Périnatalité, FHU PREMA, Colombes, France, IAME-INSERM, Paris, France
| | - C Huon
- Service de Néonatologie, AP-HP, APHP. Nord-Université de Paris, Hôpital Louis Mourier, DMU Gynécologie-Périnatalité, FHU PREMA, 178, rue des Renouillers, 92700 Colombes, France
| | - J Lepercq
- Maternité Port-Royal, AP-HP, APHP, Centre-Université de Paris, FHU PREMA, 123, Bd de Port-Royal, 75014 Paris, France
| | - F Goffinet
- Maternité Port-Royal, AP-HP, APHP, Centre-Université de Paris, FHU PREMA, 123, Bd de Port-Royal, 75014 Paris, France; Université de Paris, INSERM U1153, Équipe de recherche en Epidémiologie Obstétricale, Périnatale et Pédiatrique (EPOPé), Centre de Recherche Épidémiologie et Biostatistique Sorbonne Paris Cité (CRESS), 123, Bd de Port-Royal, 75014 Paris, France
| | - Pierre Henri Jarreau
- Service de médecine et réanimation néonatales de Port-Royal, AP-HP, APHP, Centre-Université de Paris, FHU PREMA, 123, Bd de Port-Royal, 75014 Paris, France; Université de Paris, INSERM U1153, Équipe de recherche en Epidémiologie Obstétricale, Périnatale et Pédiatrique (EPOPé), Centre de Recherche Épidémiologie et Biostatistique Sorbonne Paris Cité (CRESS), 123, Bd de Port-Royal, 75014 Paris, France.
| |
Collapse
|